Oncolytics Biotech(R) to Present at the RBC Capital Markets 2018 Healthcare Conference

CALGARY, AB and SAN DIEGO, CA–(Marketwired – February 14, 2018) – Oncolytics Biotech® Inc. (TSX: ONC) (OTCQX: ONCYF), a biotech company developing REOLYSIN®, also known as pelareorep, an intravenously delivered immuno-oncolytic virus that activates the innate and adaptive immune systems to turn “cold” tumors “hot”, today announced that it will present at the RBC Capital Markets 2018 Healthcare Conference. The presentation, by Dr. Matt Coffey, President & CEO of Oncolytics, will take place at 3:05 pm ET, on Wednesday, February 21, 2018 in the Kennedy II Room on the fourth floor of The Lotte New York Palace Hotel. The conference takes place on February 21st & 22nd in New York, NY.